Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I've been out of it for 24 hours so please forgive me if this is old news.
The Yorkshire Post says Aptamer, a partner of SKIN, « is just a couple of weeks away from having a prototype device ready and “around a month away” from having a design ready for manufacture.»
And then they need to go through the approval cycle, which is where it is believed that avacta currently are.
Please help me to understand the connections. Are the 3 companies working independently on competing products? Or are they working together? I hold both Avacta and Skin.
In other words, a fair way off! From what I have read, Aptamers are not as "exquisite" as Affimers, Affimers being the newer improved sort of version of them. Happy to conceded if I got that wrong, however. I am a holder here btw
Concede not conceded!
The breathalyser already works with covid protein spikes. How could it not work with the whole virus?
Aberdeen will verify that it works with the virus in short order, as stated in the video. This is classed as a medical device. All they have to do to get a CE mark is to prove that it works safely, reliably and accurately. It does NOT have to go anywhere near clinical trials, big pharma, the FDA or any of the other nonsense that has been dumped on this BB.
SKIN has asked for 100m production ccapacity of aptamers AND affirmers.
This is testing as it should have been all along, plus tracing, plus PROVING. No-one else has even reached this concept, but SKIN have set it all in motion. The market was right to take this up, although I suspect the MMs fired it up to allow warrants to be sold, then bought back without being exercised.
SKIN will be amazing. I don't think the SP will be stable until the warrants pass their exercise date, but now is the time to buy. The warrants holders will not settle for a 50% premium. Why would they, when they can 3 bag, as we have just seen, AND keep the warrants.
Accuracy is the key as any significant levels of false negatives could be a problem. The Aberdeen work will hopefully verify its accuracy. I agree its a medical device, however it performs a diagnostic function so suspect there maybe some regulatory hurdles to be overcome, as this is potentially uncharted water. Anyway we will see what week brings.
Ok123, avacta make affimers, and are making tests using these affimers (smaller and probably more accurate than aptemers), both personal and larger scale supervised fast tests. Skin are using affimers to make their test, and they also use aptemers.
Customer buys his reusable breathalyser, registered to his phone.
Customer buys slides (cassettes) also registered to his phone
The slide coating contains affirmers.
Covid spike proteins bind to affirmers.
Bound affirmers have different optical characteristics.
Customer places slide in breathalyser and breathes into it.
Customer inserts slide into hardware, which are modified MWG test units.
A laser is beamed through the slide and detects the registers the change/no change in light transmission.
Software creates blockchain records on customers phone and Dell cloud storage.
Positive results can feed to track and trace (logical step).
Negative results valid for 24 hours.
Attend work / event / transport.
Security scan code on phon, validated against Dell hosted blockchain record.
Customer gets his lif back, but still has to be careful.
To get a CE mark, they only have to prove that it works as reliably as other tests that have the same CE mark. No FDA, no pharma, no drama.
All proven technologies.
sgs
“ In other words, a fair way off!”
Thems what knows say Q1 2021.
Agree completely great idea and all proven tech. CE antigens tests are for professional use only, is my understanding, that's my query re some form of regulatory approval for personal use particularly for events. I maybe wrong but no matter, there is a market in workplaces. If it's very accurate which I suspect it is, it will pass all regs anyway.
Davde, it isn’t for personal use, though.
I took by own swab as part of a recent survey, but it was processed centrally. I see this as the same kind of thing. Maybe they can start by putting units in pharmacies? Somebody must be qualified to do something useful there!